SG3 Management’s Celgene Corp CELG Stock Holding History

SG3 Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,500	Closed	-$236K	–	577
2019 Q1	$236K	Buy	+2,500	New	+$219K	0.02%	225

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SG3 Management's CELG Position: Q2 2019 in Review

SG3 Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 30,000 shares — an estimated $2.85M sold.

SG3 Management first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $2.83M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

SG3 Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
SG3 Management sold 30,000 Celgene Corp shares in Q2 2019, an estimated $2.85M.
SG3 Management first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
SG3 Management's Celgene Corp position peaked at $2.83M in Q1 2019.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on SG3 Management's 13F filing for Q2 2019, filed 9 Aug 2019.